tirzepatide type 1 diabetes Tirzepatide: A Promising Drug for 2 and Beyond Can Mounjaro (tirzepatide) be used

Understanding the actual cardiac effects of this medication helps patients and clinicians make informed treatment decisions based on scientific evidence rather than misconceptions

Managing GI discomfort during dose escalation supports medication adherence, which is the critical intermediate outcome

Ozempic was initially approved by the FDA in 2017 for blood sugar control in adults with type 2 diabetes, along with diet and exercise

Consult your doctor if symptoms continue or worsen

They received subcutaneous injections of semaglutide (Ozempic, Novo Nordisk 0.5 mg injectable solution) at a dose of 30 nmol/kg body weight, or vehicle (0.9% NaCl), twice weekly until postnatal day 56 (P56)